McKesson recalls
3 notices naming McKesson as the recalling firm, since February 5, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
McKesson: Gemcitabine Injection
Hazard (FDA): Temperature Abuse: Product was stored incorrectly in a controlled room temperature environment instead of a refrigerated environment.
FDAMedicines
McKesson: UDENYCA
Hazard (FDA): Temperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment instead of the required refrigerated environment.
FDAMedicines
McKesson: Inflectra
Hazard (FDA): cGMP Deviations: Product intended for quarantine was inadvertently distributed.
FDAMedicines